Plasmodium falciparum malaria remains one of the most serious health problems globally and a protective malaria vaccine is desperately needed. Vaccination with attenuated parasites elicits multiple cellular effector mechanisms that lead to Plasmodium liver stage elimination. While granule-mediated cytotoxicity requires contact between CD8+ effector T cells and infected hepatocytes, cytokine secretion should allow parasite killing over longer distances. To better understand the mechanism of parasite elimination in vivo, we monitored the dynamics of CD8+ T cells in the livers of na？ve, immunized and sporozoite-infected mice by intravital microscopy. We found that immunization of BALB/c mice with attenuated P. yoelii 17XNL sporozoites significantly increases the velocity of CD8+ T cells patrolling the hepatic microvasculature from 2.69±0.34 μm/min in na？ve mice to 5.74±0.66 μm/min, 9.26±0.92 μm/min, and 7.11±0.73 μm/min in mice immunized with irradiated, early genetically attenuated (Pyuis4-deficient), and late genetically attenuated (Pyfabb/f-deficient) parasites, respectively. Sporozoite infection of immunized mice revealed a 97% and 63% reduction in liver stage density and volume, respectively, compared to na？ve controls. To examine cellular mechanisms of immunity in situ, na？ve mice were passively immunized with hepatic or splenic CD8+ T cells. Unexpectedly, adoptive transfer rendered the motile CD8+ T cells from immunized mice immotile in the liver of P. yoelii infected mice. Similarly, when mice were simultaneously inoculated with viable sporozoites and CD8+ T cells, velocities 18 h later were also significantly reduced to 0.68±0.10 μm/min, 1.53±0.22 μm/min, and 1.06±0.26 μm/min for CD8+ T cells from mice immunized with irradiated wild type sporozoites, Pyfabb/f-deficient parasites, and P. yoelii CS280–288 peptide, respectively. Because immobilized CD8+ T cells are unable to make contact with infected hepatocytes, soluble mediators could potentially play a key role in parasite elimination under these experimental conditions.
References
[1]
WHO (2011) World Malaria Report: 2011. Geneva, Switzerland: World Health Organization.
[2]
Nussenzweig V, Nussenzweig RS (1989) Rationale for the development of an engineered sporozoite malaria vaccine. Adv Immunol 45: 283–334.
[3]
Kumar KA, Sano G, Boscardin S, Nussenzweig RS, Nussenzweig MC, et al. (2006) The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites. Nature 444: 937–940.
[4]
Cohen J, Nussenzweig V, Nussenzweig R, Vekemans J, Leach A (2010) From the circumsporozoite protein to the RTS, S/AS candidate vaccine. Hum Vaccin 6: 90–96.
[5]
Rts SCTP, Agnandji ST, Lell B, Fernandes JF, Abossolo BP, et al. (2012) A phase 3 trial of RTS, S/AS01 malaria vaccine in African infants. N Engl J Med 367: 2284–2295.
[6]
Nussenzweig RS, Vanderberg J, Most H, Orton C (1967) Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. Nature 216: 160–162.
[7]
Clyde DF, Most H, McCarthy VC, Vanderberg JP (1973) Immunization of man against sporozoite-induced falciparum malaria. Am J Med Sci 266: 169–177.
[8]
Clyde DF (1990) Immunity to falciparum and vivax malaria induced by irradiated sporozoites: a review of the University of Maryland studies, 1971–75. Bull World Health Organ 68 Suppl: 9–12
[9]
Herrington DA, Clyde DF, Davis JR, Baqar S, Murphy JR, et al. (1990) Human studies with synthetic peptide sporozoite vaccine (NANP)3-TT and immunization with irradiated sporozoites. Bull World Health Organ 68 Suppl: 33–37
[10]
Egan JE, Hoffman SL, Haynes JD, Sadoff JC, Schneider I, et al. (1993) Humoral immune responses in volunteers immunized with irradiated Plasmodium falciparum sporozoites. Am J Trop Med Hyg 49: 166–173.
[11]
Hoffman SL, Goh LM, Luke TC, Schneider I, Le TP, et al. (2002) Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis 185: 1155–1164.
[12]
Roestenberg M, McCall M, Hopman J, Wiersma J, Luty AJF, et al. (2009) Protection against a malaria challenge by sporozoite inoculation. New Engl J Med 361: 468–477.
[13]
Epstein JE, Tewari K, Lyke KE, Sim BK, Billingsley PF, et al. (2011) Live attenuated malaria vaccine designed to protect through hepatic CD8 T cell immunity. Science 334: 475–480.
[14]
Sun P, Schwenk R, White K, Stoute JA, Cohen J, et al. (2003) Protective immunity induced with malaria vaccine, RTS, S, is linked to Plasmodium falciparum circumsporozoite protein-specific CD4+ and CD8+ T cells producing IFN-gamma. J Immunol 171: 6961–6967.
[15]
Schmidt NW, Butler NS, Badovinac VP, Harty JT (2010) Extreme CD8 T cell requirements for anti-malarial liver-stage immunity following immunization with radiation attenuated sporozoites. PLoS Pathog 6: e1000998.
[16]
Conteh S, Chattopadhyay R, Anderson C, Hoffman SL (2010) Plasmodium yoelii-Infected An. stephensi inefficiently transmit malaria compared to intravenous route. PLoS ONE 5: e8947.
[17]
Tarun AS, Dumpit RF, Camargo N, Labaied M, Liu P, et al. (2007) Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells. J Infect Dis 196: 608–616.
[18]
Butler NS, Schmidt NW, Vaughan AM, Aly AS, Kappe SH, et al. (2011) Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites. Cell Host Microbe 9: 451–462.
[19]
Labaied M, Harupa A, Dumpit RF, Coppens I, Mikolajczak SA, et al. (2007) Plasmodium yoelii sporozoites with simultaneous deletion of P52 and P36 are completely attenuated and confer sterile immunity against infection. Infect Immun 75: 3758–3768.
[20]
Kumar KA, Baxter P, Tarun AS, Kappe SH, Nussenzweig V (2009) Conserved protective mechanisms in radiation and genetically attenuated uis3(？) and uis4(？) Plasmodium sporozoites. PLoS ONE 4: e4480.
[21]
Vaughan AM, O'Neill MT, Tarun AS, Camargo N, Phuong TM, et al. (2009) Type II fatty acid synthesis is essential only for malaria parasite late liver stage development. Cell Microbiol 11: 506–520.
[22]
Berenzon D, Schwenk RJ, Letellier L, Guebre-Xabier M, Williams J, et al. (2003) Protracted protection to Plasmodium berghei malaria is linked to functionally and phenotypically heterogeneous liver memory CD8+ T cells. J Immunol 171: 2024–2034.
[23]
Douradinha B, van Dijk MR, Ataide R, van Gemert GJ, Thompson J, et al. (2007) Genetically attenuated P36p-deficient Plasmodium berghei sporozoites confer long-lasting and partial cross-species protection. Int J Parasitol 37: 1511–1519.
[24]
VanBuskirk KM, O'Neill MT, De La Vega P, Maier AG, Krzych U, et al. (2009) Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design. Proc Natl Acad Sci U S A 106: 13004–13009.
[25]
Jobe O, Lumsden J, Mueller AK, Williams J, Silva-Rivera H, et al. (2007) Genetically attenuated Plasmodium berghei liver stages induce sterile protracted protection that is mediated by major histocompatibility complex Class I-dependent interferon-gamma-producing CD8+ T cells. J Infect Dis 196: 599–607.
[26]
Purcell LA, Wong KA, Yanow SK, Lee M, Spithill TW, et al. (2008) Chemically attenuated Plasmodium sporozoites induce specific immune responses, sterile immunity and cross-protection against heterologous challenge. Vaccine 26: 4880–4884.
[27]
Belnoue E, Voza T, Costa FT, Gruner AC, Mauduit M, et al. (2008) Vaccination with live Plasmodium yoelii blood stage parasites under chloroquine cover induces cross-stage immunity against malaria liver stage. J Immunol 181: 8552–8558.
[28]
Schmidt NW, Podyminogin RL, Butler NS, Badovinac VP, Tucker BJ, et al. (2008) Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria. Proc Natl Acad Sci U S A 105: 14017–14022.
[29]
Nganou-Makamdop K, Sauerwein RW (2013) Liver or blood-stage arrest during malaria sporozoite immunization: the later the better? Trends Parasitol [Epub ahead of print].
[30]
Vanderberg JP, Frevert U (2004) Intravital microscopy demonstrating antibody-mediated immobilization of Plasmodium berghei sporozoites injected into skin by mosquitoes. Int J Parasitol 34: 991–996.
[31]
Amino R, Thiberge S, Martin B, Celli S, Shorte S, et al. (2006) Quantitative imaging of Plasmodium transmission from mosquito to mammal. Nat Med 12: 220–224.
[32]
Baer K, Roosevelt M, Van Rooijen N, Clarkson Jr AB, Schnieder T, et al. (2007) Kupffer cells are obligatory for Plasmodium sporozoite infection of the liver. Cell Microbiol 9: 397–412.
[33]
Pradel G, Frevert U (2001) Plasmodium sporozoites actively enter and pass through Kupffer cells prior to hepatocyte invasion. Hepatology 33: 1154–1165.
[34]
Tavares J, Formaglio P, Thiberge S, Mordelet E, Van Rooijen N, et al.. (2013) Role of host cell traversal by the malaria sporozoite during liver infection. J Exp Med [Epub ahead of print].
[35]
Frevert U, Engelmann S, Zougbédé S, Stange J, Ng B, et al. (2005) Intravital observation of Plasmodium berghei sporozoite infection of the liver. PLoS Biol 3: e192.
[36]
Mota MM, Pradel G, Vanderberg JP, Hafalla JC, Frevert U, et al. (2001) Migration of Plasmodium sporozoites through cells before infection. Science 291: 141–144.
[37]
Stewart MJ, Vanderberg JP (1991) Malaria sporozoites release circumsporozoite protein from their apical end and translocate it along their surface. J Protozool 38: 411–421.
[38]
Stewart MJ, Vanderberg JP (1988) Malaria sporozoites leave behind trails of circumsporozoite protein during gliding motility. J Protozool 35: 389–393.
[39]
Spaccapelo R, Naitza S, Robson KJH, Crisanti A (1997) Thrombospondin-related adhesive protein (TRAP) of Plasmodium berghei and parasite motility. Lancet 350.
[40]
Frevert U, Galinski MR, Hügel F-U, Allon N, Schreier H, et al. (1998) Malaria circumsporozoite protein inhibits protein synthesis in mammalian cells. EMBO J 17: 3816–3826.
[41]
Hügel F-U, Pradel G, Frevert U (1996) Release of malaria circumsporozoite protein into the host cell cytoplasm and interaction with ribosomes. Mol Biochem Parasitol 81: 151–170.
[42]
Crispe IN (2011) Liver antigen-presenting cells. J Hepatol 54: 357–365.
[43]
Knolle PA, Limmer A (2001) Neighborhood politics: the immunoregulatory function of organ-resident liver endothelial cells. Trends Immunol 22: 432–437.
[44]
Steers N, Schwenk R, Bacon DJ, Berenzon D, Williams J, et al.. (2005) The immune status of Kupffer cells profoundly influences their responsiveness to infectious Plasmodium berghei sporozoites. Eur J Immunol in press.
[45]
Racanelli V, Rehermann B (2006) The liver as an immunological organ. Hepatology 43: S54–62.
[46]
Crispe IN (2009) The liver as a lymphoid organ. Annu Rev Immunol 27: 147–163.
[47]
Frevert U, Nardin E (2008) Cellular effector mechanisms against Plasmodium liver stages. Cell Microbiol 10: 1956–1967.
[48]
Steers N, Schwenk R, Bacon DJ, Berenzon D, Williams J, et al. (2005) The immune status of Kupffer cells profoundly influences their responses to infectious Plasmodium berghei sporozoites. Eur J Immunol 35: 2335–2346.
[49]
Klotz C, Frevert U (2008) Plasmodium sporozoites modulate cytokine secretion profile and induce apoptosis in murine Kupffer cells. Int J Parasitol 38: 1639–1650.
[50]
Usynin I, Klotz C, Frevert U (2007) Malaria circumsporozoite protein inhibits the respiratory burst in Kupffer cells. Cell Microbiol 9: 2610–2628.
[51]
Doolan DL, Hoffman SL (2000) The complexity of protective immunity against liver-stage malaria. J Immunol 165: 1453–1492.
[52]
Tsuji M (2010) A retrospective evaluation of the role of T cells in the development of malaria vaccine. Exp Parasitol 126: 421–425.
[53]
Overstreet MG, Cockburn IA, Chen YC, Zavala F (2008) Protective CD8 T cells against Plasmodium liver stages: immunobiology of an 'unnatural' immune response. Immunol Rev 225: 272–283.
[54]
Doolan DL, Martinez-Alier N (2006) Immune response to pre-erythrocytic stages of malaria parasites. Curr Mol Med 6: 169–185.
[55]
Krzych U, Schwenk J (2005) The dissection of CD8 T cells during liver-stage infection. Curr Top Microbiol Immunol 297: 1–24.
[56]
Bongfen SE, Torgler R, Romero JF, Renia L, Corradin G (2007) Plasmodium berghei-infected primary hepatocytes process and present the circumsporozoite protein to specific CD8+ T cells in vitro. J Immunol 178: 7054–7063.
[57]
Rénia L, Marussig MS, Grillot D, Pied S, Corradin G, et al. (1991) In vitro activity of CD4+ and CD 8+ T lymphocytes from mice immunized with a synthetic malaria peptide. Proc Natl Acad Sci USA 88: 7963–7967.
[58]
Trimnell A, Takagi A, Gupta M, Richie TL, Kappe SH, et al. (2009) Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes. J Immunol 183: 5870–5878.
[59]
Butler NS, Vaughan AM, Harty JT, Kappe SH (2012) Whole parasite vaccination approaches for prevention of malaria infection. Trends Immunol 33: 247–254.
[60]
Muller AJ, Filipe-Santos O, Eberl G, Aebischer T, Spath GF, et al. (2012) CD4(+) T cells rely on a cytokine gradient to control intracellular pathogens beyond sites of antigen presentation. Immunity 37: 147–157.
[61]
Frevert U, Nacer A (2013) Immunobiology of Plasmodium in liver and brain. Parasite Immunol: In press.
[62]
Tarun AS, Baer K, Dumpit RF, Gray S, Lejarcegui N, et al. (2006) Quantitative isolation and in vivo imaging of malaria parasite liver stages. Int J Parasitol 36: 1283–1293.
[63]
Motoike T, Loughna S, Perens E, Roman BL, Liao W, et al. (2000) Universal GFP reporter for the study of vascular development. genesis 28: 75–81.
[64]
Cabrera M, Frevert U (2012) Novel in vivo imaging techniques for the liver microvasculature. IntraVital 1: 107–114.
[65]
Baer K, Klotz C, Kappe SHIK, Schnieder T, Frevert U (2007) Release of hepatic Plasmodium yoelii merozoites into the pulmonary microvasculature. PLoS Pathog 3: e171.
[66]
Butler NS, Schmidt NW, Harty JT (2010) Differential effector pathways regulate memory CD8 T cell immunity against Plasmodium berghei versus P. yoelii sporozoites. J Immunol 184: 2528–2538.
[67]
Schmidt NW, Butler NS, Harty JT (2011) Plasmodium-host interactions directly influence the threshold of memory CD8 T cells required for protective immunity. J Immunol 186: 5873–5884.
[68]
Crispe IN (2001) Isolation of mouse intrahepatic lymphocytes. Curr Protoc Immunol Chapter 3: Unit 3 21.
[69]
Vaughan AM, Kappe SH (2013) Vaccination using radiation- or genetically attenuated live sporozoites. Methods Mol Biol 923: 549–566.
[70]
Egen JG, Rothfuchs AG, Feng CG, Horwitz MA, Sher A, et al. (2011) Intravital imaging reveals limited antigen presentation and T cell effector function in mycobacterial granulomas. Immunity 34: 807–819.
[71]
Bajenoff M, Narni-Mancinelli E, Brau F, Lauvau G (2010) Visualizing early splenic memory CD8+ T cells reactivation against intracellular bacteria in the mouse. PLoS One 5: e11524.
[72]
Frevert U, Moreno A, Calvo Calle JM, Klotz C, Nardin E (2008) Imaging human cytotoxic CD4+ T cells specific for Plasmodium falciparum circumsporozoite protein. Int J Parasitol 39: 119–132.
[73]
Chakravarty S, Baldeviano GC, Overstreet MG, Zavala F (2008) Effector CD8+ T lymphocytes against liver stages of Plasmodium yoelii do not require gamma interferon for antiparasite activity. Infect Immun 76: 3628–3631.
[74]
Morrot A, Cockburn IA, Overstreet M, Rodriguez D, Zavala F (2006) Protective CD8+ T cells induced by malaria sporozoites do not undergo modulation of interleukin-7 receptor expression. Infect Immun 74: 2495–2497.
[75]
Stoyanov CT, Boscardin SB, Deroubaix S, Barba-Spaeth G, Franco D, et al. (2010) Immunogenicity and protective efficacy of a recombinant yellow fever vaccine against the murine malarial parasite Plasmodium yoelii. Vaccine 28: 4644–4652.
[76]
Friedl P, Weigelin B (2008) Interstitial leukocyte migration and immune function. Nat Immunol 9: 960–969.
[77]
Zarling S, Berenzon D, Dalai S, Liepinsh D, Steers N, et al.. (2013) The Survival of Memory CD8 T Cells That Is Mediated by IL-15 Correlates with Sustained Protection Against Malaria. J Immunol.
[78]
Krzych U, Dalai S, Zarling S, Pichugin A (2012) Memory CD8 T cells specific for plasmodia liver-stage antigens maintain protracted protection against malaria. Front Immunol 3: 370.
[79]
Nganou-Makamdop K, Ploemen I, Behet M, van Gemert GJ, Hermsen C, et al.. (2012) Reduced Plasmodium berghei sporozoite liver load associates with low protective efficacy after intradermal immunization. Parasite Immunol.
[80]
Morrot A, Zavala F (2004) Effector and memory CD8+ T cells as seen in immunity to malaria. Immunol Rev 201: 291–303.
[81]
Rodrigues MM, Cordey AS, Arreaza G, Corradin G, Romero P, et al. (1991) CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria. Int Immunol 3: 579–585.
[82]
Sano G, Hafalla JC, Morrot A, Abe R, Lafaille JJ, et al. (2001) Swift development of protective effector functions in naive CD8(+) T cells against malaria liver stages. J Exp Med 194: 173–180.
[83]
Vanderberg JP, Nussenzweig RS, Most H, Orton CG (1968) Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. II. Effects of radiation on sporozoites. J Parasitol 54: 1175–1180.
[84]
Chakravarty S, Cockburn IA, Kuk S, Overstreet MG, Sacci JB, et al. (2007) CD8(+) T lymphocytes protective against malaria liver stages are primed in skin-draining lymph nodes. Nat Med 13: 1035–1041.
[85]
Renggli J, Hahne M, Matile H, Betschart B, Tschopp J, et al. (1997) Elimination of P. berghei liver stages is independent of Fas (CD95/Apo-I) or perforin-mediated cytotoxicity. Parasite Immunol 19: 145–148.
[86]
Cockburn IA, Chakravarty S, Overstreet MG, Garcia-Sastre A, Zavala F (2008) Memory CD8+ T cell responses expand when antigen presentation overcomes T cell self-regulation. J Immunol 180: 64–71.
[87]
Tsuji M, Miyahira Y, Nussenzweig RS, Aguet M, Reichel M, et al. (1995) Development of antimalaria immunity in mice lacking IFN-gamma receptor. J Immunol 154: 5338–5344.
[88]
Hoffman SL, Isenbarger D, Long GW, Sedegah M, Szarfman A, et al. (1989) Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes. Science 244: 1078–1081.
[89]
Hoffman SL, Isenbarger D, Long GW, Sedegah M, Szarfman A, et al. (1990) T lymphocytes from mice immunized with irradiated sporozoites eliminate malaria from hepatocytes. Bull World Health Organ 68 Suppl: 132–137
[90]
Mellouk S, Green SJ, Nacy CA, Hoffman SL (1991) IFN-gamma inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism. J Immunol 146: 3971–3976.
[91]
Mueller AK, Deckert M, Heiss K, Goetz K, Matuschewski K, et al. (2007) Genetically attenuated Plasmodium berghei liver stages persist and elicit sterile protection primarily via CD8 T cells. Am J Pathol 171: 107–115.
[92]
Seguin MC, Klotz FW, Schneider I, Weir JP, Goodbary M, et al. (1994) Induction of nitric oxide synthase protects against malaria in mice exposed to irradiated Plasmodium berghei infected mosquitoes: involvement of interferon gamma and CD8+ T cells. J Exp Med 180: 353–358.
[93]
Weiss WR, Berzofsky JA, Houghten RA, Sedegah M, Hollindale M, et al. (1992) A T cell clone directed at the circumsporozoite protein which protects mice against both Plasmodium yoelii and Plasmodium berghei. J Immunol 149: 2103–2109.
[94]
Ferreira A, Schofield L, Enea V, Schellekens H, van der Meide P, et al. (1986) Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon. Science 232: 881–884.
[95]
Schofield L, Ferreira A, Altszuler R, Nussenzweig V, Nussenzweig RS (1987) Interferon-gamma inhibits the intrahepatocytic development of malaria parasites in vitro. J Immunol 139: 2020–2025.
[96]
Mellouk S, Maheshwari RK, Rhodes-Feuilette A, Beaudoin RL, Berbibuier N, et al. (1987) Inhibitory activity of interferons and interleukin 1 on the development of Plasmodium falciparum in human hepatocyte cultures. J Immunol 139: 4192–4195.
[97]
Klotz FW, Scheller LF, Seguin MC, Kumar N, Marletta MA, et al. (1995) Co-localization of inducible-nitric oxide synthase and Plasmodium berghei in hepatocytes from rats immunized with irradiated sporozoites. J Immunol 154: 3391–3395.
[98]
Nussler AK, Renia L, Pasquetto V, Miltgen F, Matile H, et al. (1993) In vivo induction of the nitric oxide pathway in hepatocytes after injection with irradiated malaria sporozoites, malaria blood parasites or adjuvants. Eur J Immunol 23: 882–887.
[99]
Schofield L, Villaquiran J, Ferreira A, Schellekens H, Nussenzweig R, et al. (1987) Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature 330: 664–666.
[100]
Weiss WR, Sedegah M, Beaudoin RL, Miller LH, Good MF (1988) CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc Natl Acad Sci USA 85: 573–576.
[101]
Doolan DL, Hoffman SL (1999) IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model. J Immunol 163: 884–892.
[102]
Berg RE, Crossley E, Murray S, Forman J (2005) Relative contributions of NK and CD8 T cells to IFN-gamma mediated innate immune protection against Listeria monocytogenes. J Immunol 175: 1751–1757.
[103]
McCall MB, Sauerwein RW (2010) Interferon-gamma–central mediator of protective immune responses against the pre-erythrocytic and blood stage of malaria. J Leukoc Biol 88: 1131–1143.
[104]
Bertolino P, McCaughan GW, Bowen DG (2002) Role of primary intrahepatic T-cell activation in the 'liver tolerance effect'. Immunol Cell Biol 80: 84–92.
[105]
Mackay IR (2002) Hepatoimmunology: a perspective. Immunol Cell Biol 80: 36–44.
[106]
Sheth K, Bankey P (2001) The liver as an immune organ. Curr Opin Crit Care 7: 99–104.
[107]
Ohtani O, Ohtani Y (2008) Lymph circulation in the liver. Anat Rec (Hoboken) 291: 643–652.
[108]
Trutmann M, Sasse D (1994) The lymphatics of the liver. Anat Embryol (Berl) 190: 201–209.
[109]
Magari S (1990) Hepatic lymphatic system: structure and function. J Gastroenterol Hepatol 5: 82–93.
[110]
Henriksen JH, Horn T, Christoffersen P (1984) The blood-lymph barrier in the liver. A review based on morphological and functional concepts of normal and cirrhotic liver. Liver 4: 221–232.
[111]
Greenway CV, Lautt WW (1970) Effects of hepatic venous pressure on transsinusoidal fluid transfer in the liver of the anesthetized cat. Circ Res 26: 697–703.
[112]
Laine GA, Hall JT, Laine SH, Granger J (1979) Transsinusoidal fluid dynamics in canine liver during venous hypertension. Circ Res 45: 317–323.
[113]
Wisse E, De Zanger RB, Jacobs R, McCuskey RS (1983) Scanning electron microscope observations on the structure of portal veins, sinusoids and central veins in rat liver. Scan Electron Microsc 3: 1441–1452.
[114]
Sedegah M, Weiss WW, Hoffman SL (2007) Cross-protection between attenuated Plasmodium berghei and P. yoelii sporozoites. Parasite Immunol 29: 559–565.
[115]
Douradinha B, Mota MM, Luty AJ, Sauerwein RW (2008) Cross-species immunity in malaria vaccine development: two, three, or even four for the price of one? Infect Immun 76: 873–878.
[116]
Nussenzweig RS, Vanderberg J, Spitalny GL, Rivera CI, Orton C, et al. (1972) Sporozoite-induced immunity in mammalian malaria. A review. Am J Trop Med Hyg 21: 722–728.
[117]
Nussenzweig RS, Vanderberg JP, Most H, Orton C (1969) Specificity of protective immunity produced by x-irradiated Plasmodium berghei sporozoites. Nature 222: 488–489.
Belnoue E, Costa FT, Frankenberg T, Vigario AM, Voza T, et al. (2004) Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment. J Immunol 172: 2487–2495.
[120]
Klein I, Cornejo JC, Polakos NK, John B, Wuensch SA, et al. (2007) Kupffer cell heterogeneity: functional properties of bone marrow derived and sessile hepatic macrophages. Blood 110: 4077–4085.
[121]
Clark IA, Budd AC, Alleva LM, Cowden WB (2006) Human malarial disease: a consequence of inflammatory cytokine release. Malar J 5: 85.
[122]
Danforth HD, Aikawa M, Cochrane AH, Nussenzweig RS (1980) Sporozoites of mammalian malaria: attachment to, interiorization and fate within macrophages. J Protozool 27: 193–202.
[123]
Seguin MC, Ballou WR, Nacy CA (1989) Interactions of Plasmodium berghei sporozoites and murine Kupffer cells in vitro. J Immunol 143: 1716–1722.
[124]
Jobe O, Donofrio G, Sun G, Liepinsh D, Schwenk R, et al. (2009) Immunization with radiation-attenuated Plasmodium berghei sporozoites induces liver cCD8alpha+DC that activate CD8+T cells against liver-stage malaria. PLoS ONE 4: e5075.
[125]
Mazier D, Mellouk S, Beaudoin RL, Texier B, Druilhe P, et al. (1986) Effect of antibodies to recombinant and synthetic peptides on P. falciparum sporozoites in vitro. Science 231: 156–159.
[126]
Nudelman S, Rénia L, Charoenvit Y, Yuan L, Miltgen F, et al. (1989) Dual action of anti-sporozoite antibodies in vitro. J Immunol 143: 996–1000.
[127]
Krzych U, Schwenk R, Guebre-Xabier M, Sun P, Palmer D, et al. (2000) The role of intrahepatic lymphocytes in mediating protective immunity induced by attenuated Plasmodium berghei sporozoites. Immunol Rev 174: 123–134.
[128]
Park S, Murray D, John B, Crispe IN (2002) Biology and significance of T-cell apoptosis in the liver. Immunol Cell Biol 80: 74–83.
[129]
John B, Crispe IN (2004) Passive and active mechanisms trap activated CD8+ T cells in the liver. J Immunol 172: 5222–5229.
[130]
Rodrigues M, Nussenzweig RS, Romero P, Zavala F (1992) The in vivo cytotoxic activity of CD8+ T cell clones correlates with their levels of expression of adhesion molecules. J Exp Med 175: 895–905.
[131]
Guebre-Xabier M, Schwenk R, Krzych U (1999) Memory phenotype CD8(+) T cells persist in livers of mice protected against malaria by immunization with attenuated Plasmodium berghei sporozoites. Eur J Immunol 29: 3978–3986.
[132]
Krzych U, Schwenk R, Guebre-Xabier M, Sun P, Palmer D, et al. (2000) The role of intrahepatic lymphocytes in mediating protective immunity induced by attenuated Plasmodium berghei sporozoites. Immunol Rev 174: 1–12.
[133]
McDonald B, McAvoy EF, Lam F, Gill V, de la Motte C, et al. (2008) Interaction of CD44 and hyaluronan is the dominant mechanism for neutrophil sequestration in inflamed liver sinusoids. J Exp Med 205: 915–927.
